DPP-4 inhibitors × glycemic control

TrialDiabetic medicine : a journal of the British Diabetic Association2014

Linagliptin improved glycaemic control without weight gain or hypoglycaemia in patients with type 2 diabetes inadequately controlled by a combination of metformin and pioglitazone: a 24-week randomized, double-blind study.

M Bajaj et al.PubMed ↗Full text ↗Publisher ↗

What the trial testedas reported · 272 people · 2014

No range given

Reported higher glycemic control, no range given

2.9×

Bigger than 7 in 10 for glycemic control

As reported

OR 2.94, no interval

One number in the abstract

the abstract, start to end

HbA1c < 53 mmol/mol (7.0%) (odds ratio 2.94; P = 0.0033).

← favours treatmentfavours comparator →
could be chance
No interval given · direction only, strength unknown
Glycemic control
OR 2.94
DPP-4 inhibitorsGlycemic control

DPP-4 inhibitors × glycemic controlhelps?replicated

unlikelylikely
0.820.82 without it
← favours comparatorfavours treatment →
this papermore certainless certain
1 / 5

18 papers cite it

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 24824197